您的位置: 首页 > 农业专利 > 详情页

Use the method comprising liposome Irinotecan and the combination therapy to treat metastatic cancer of pancreas of oxaliplatin
专利权人:
IPSEN BIOPHARM LTD
发明人:
ASHISH KALRA,BART S. HENDRIKS,DANIEL F. GADDY,ELIEL BAYEVER,HELEN LEE,JONATHAN BASIL FITZGERALD,SARAH F. BLANCHETTE
申请号:
BR112018002941
公开号:
BR112018002941A2
申请日:
2016.08.19
申请国别(地区):
BR
年份:
2018
代理人:
摘要:
Combination treatment scheme including liposome Irinotecan, oxaliplatin and 5 fluorouracils can be used for treating cancer of pancreas, include patient of the treatment diagnosis with previous untreated metastatic pancreas adenocarcinoma.The combination treatment may include applying liposome Irinotecan, oxaliplatin, folinic acid and 5 fluorouracils once every two weeks.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充